We are live on ! Find out more
ATRC icon

AtriCure

113 hedge funds and large institutions have $422M invested in AtriCure in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

37% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 38

1% more capital invested

Capital invested by funds: $418M → $422M (+$4.35M)

2% less funds holding

Funds holding: 115113 (-2)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

Holders
113
Holders Change
-2
Holders Change %
-1.74%
% of All Funds
3.25%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.14%
New
14
Increased
52
Reduced
38
Closed
16
Calls
$18K
Puts
Net Calls
+$18K
Net Calls Change
-$183K
Name Holding Trade Value Shares
Change
Change in
Stake
CCMH
126
Cornerstone Capital Management Holdings
New York
-$167K -8,900 Closed
SG Americas Securities
127
SG Americas Securities
New York
-$131K -6,962 Closed
CCS
128
Crosspoint Capital Strategies
California
-$15K -800 Closed
GC
129
Globeflex Capital
California
-$166 -10 -17%

ATRC Hedge Fund Activity: Q2 2014 in Review

113 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q2 2014, worth a combined $422M — up 1% from $418M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of ATRC and 14 opened new positions — a net loss of 2 holders — while 38 trimmed existing stakes and 52 added.

The largest buyer was Adage Capital Partners, adding an estimated $6.91M. The largest seller was Numeric Investors, exiting entirely with an estimated $5.97M sold.

  • 113 institutional investors held AtriCure (ATRC) as of Q2 2014, down from 115 in Q1 2014.
  • Funds reported $422M of AtriCure stock for Q2 2014, up 1% quarter-over-quarter.
  • 14 funds opened new AtriCure positions in Q2 2014 and 16 closed out, a net change of -2 holders.
  • The largest AtriCure buyer in Q2 2014 was Adage Capital Partners, an estimated $6.91M added.
  • The largest AtriCure seller in Q2 2014 was Numeric Investors, an estimated $5.97M sold.

Based on aggregated 13F filings for Q2 2014.